1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
Star0
Identification
- Generic Name
- 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL
- DrugBank Accession Number
- DB07119
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 270.71
Monoisotopic: 270.044757303 - Chemical Formula
- C16H11ClO2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UNuclear receptor coactivator 1 Not Available Humans UEstrogen receptor beta Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as phenylnaphthalenes. These are compounds containing a phenylnaphthalene skeleton, which consists of a naphthalene bound to a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Naphthalenes
- Sub Class
- Phenylnaphthalenes
- Direct Parent
- Phenylnaphthalenes
- Alternative Parents
- Naphthols and derivatives / Chloronaphthalenes / 1-hydroxy-2-unsubstituted benzenoids / Benzene and substituted derivatives / Aryl chlorides / Organooxygen compounds / Organochlorides / Hydrocarbon derivatives
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / 2-naphthol / Aromatic homopolycyclic compound / Aryl chloride / Aryl halide / Chloronaphthalene / Hydrocarbon derivative / Monocyclic benzene moiety / Organic oxygen compound / Organochloride
- Molecular Framework
- Aromatic homopolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- YHEHVRSGKUYDON-UHFFFAOYSA-N
- InChI
- InChI=1S/C16H11ClO2/c17-16-14-7-3-11(9-12(14)4-8-15(16)19)10-1-5-13(18)6-2-10/h1-9,18-19H
- IUPAC Name
- 1-chloro-6-(4-hydroxyphenyl)naphthalen-2-ol
- SMILES
- OC1=CC=C(C=C1)C1=CC=C2C(C=CC(O)=C2Cl)=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 6102690
- PubChem Substance
- 99443590
- ChemSpider
- 4810212
- BindingDB
- 50168323
- ChEMBL
- CHEMBL364092
- ZINC
- ZINC000013645009
- PDBe Ligand
- 4NA
- PDB Entries
- 1yy4
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0063 mg/mL ALOGPS logP 4.35 ALOGPS logP 4.61 Chemaxon logS -4.6 ALOGPS pKa (Strongest Acidic) 7.78 Chemaxon pKa (Strongest Basic) -5.5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 40.46 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 76.41 m3·mol-1 Chemaxon Polarizability 28.32 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.8374 Caco-2 permeable + 0.8428 P-glycoprotein substrate Non-substrate 0.6911 P-glycoprotein inhibitor I Non-inhibitor 0.9493 P-glycoprotein inhibitor II Non-inhibitor 0.9122 Renal organic cation transporter Non-inhibitor 0.8743 CYP450 2C9 substrate Non-substrate 0.7826 CYP450 2D6 substrate Non-substrate 0.8727 CYP450 3A4 substrate Non-substrate 0.5958 CYP450 1A2 substrate Inhibitor 0.945 CYP450 2C9 inhibitor Inhibitor 0.9485 CYP450 2D6 inhibitor Non-inhibitor 0.8624 CYP450 2C19 inhibitor Inhibitor 0.7858 CYP450 3A4 inhibitor Non-inhibitor 0.8566 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7782 Ames test Non AMES toxic 0.8029 Carcinogenicity Non-carcinogens 0.7935 Biodegradation Not ready biodegradable 0.9903 Rat acute toxicity 2.3868 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8848 hERG inhibition (predictor II) Non-inhibitor 0.7922
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available
Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsNuclear receptor coactivator 1
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Transcription coactivator activity
- Specific Function
- Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear re...
- Gene Name
- NCOA1
- Uniprot ID
- Q15788
- Uniprot Name
- Nuclear receptor coactivator 1
- Molecular Weight
- 156755.44 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
2. DetailsEstrogen receptor beta
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent m...
- Gene Name
- ESR2
- Uniprot ID
- Q92731
- Uniprot Name
- Estrogen receptor beta
- Molecular Weight
- 59215.765 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:19 / Updated at June 12, 2020 16:52